4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-003293
Options or other derivatives
- Chief Financial Officer acquired 90,090 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Holm-Jorgensen Rasmus · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +90,090 | 90,090 | D |
Loading xslF345X05/form4.xml…